ReachMD
Be part of the knowledge.™Key Findings for the Treatment of Adult Patients with Moderate Plaque Psoriasis
DermConsultKey Findings for the Treatment of Adult Patients with Moderate Plaque Psoriasis
Diving into the Details of Bile Acids, Lipids, and Nucleotides in Psoriatic Arthritis
Clinician's RoundtableDiving into the Details of Bile Acids, Lipids, and Nucleotides in Psoriatic Arthritis
FDA Approves New Treatment for Moderate-to-Severe Plaque Psoriasis
DermConsultFDA Approves New Treatment for Moderate-to-Severe Plaque Psoriasis
Biosimilars in Psoriasis: The Future of Treatment
DermConsultBiosimilars in Psoriasis: The Future of Treatment
Treating Atopic Dermatitis: A Look at the Current & Future Landscape
DermConsultTreating Atopic Dermatitis: A Look at the Current & Future Landscape
Improving Management of Atopic Dermatitis in Children and Adults with Novel Therapies
CME/CEImproving Management of Atopic Dermatitis in Children and Adults with Novel Therapies
Enhancing Care in Moderate to Severe Psoriasis: Treatment Selection
CME/CEEnhancing Care in Moderate to Severe Psoriasis: Treatment Selection
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
CME/CEDirected Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
KALMing the Itch: Improving QoL in Patients with CKD-aP
CME/CEKALMing the Itch: Improving QoL in Patients with CKD-aP
Preventing Disease Recurrence with Adjuvant Therapy in Stage IIB/IIC Melanoma
CME/CEPreventing Disease Recurrence with Adjuvant Therapy in Stage IIB/IIC Melanoma
Separating Fact from Fiction: The Realities of CKD-aP
CME/CESeparating Fact from Fiction: The Realities of CKD-aP
Treating Psoriatic Arthritis (PsA) and Ankylosing Spondylitis (AS): A Virtual Simulation
Medical Industry FeatureTreating Psoriatic Arthritis (PsA) and Ankylosing Spondylitis (AS): A Virtual Simulation
Expanding Treatment Options for Patients 12 Years of Age and Older With Moderate-to-Severe Atopic Dermatitis
Medical Industry FeatureExpanding Treatment Options for Patients 12 Years of Age and Older With Moderate-to-Severe Atopic Dermatitis
From Heterogeneity Comes New Insights: Exploring the Role of T Cells & OX40 Signaling in Atopic Dermatitis
Medical Industry FeatureFrom Heterogeneity Comes New Insights: Exploring the Role of T Cells & OX40 Signaling in Atopic Dermatitis
Inflammation Biosimilars: Examining the Totality of Evidence for Approval
Medical Industry FeatureInflammation Biosimilars: Examining the Totality of Evidence for Approval
Enhancing Your Aesthetic Skillset: A New Training and Educational Hub
Medical Industry FeatureEnhancing Your Aesthetic Skillset: A New Training and Educational Hub
An Rx Option for Adults with Moderate-to-Severe Plaque Psoriasis
Medical Industry FeatureAn Rx Option for Adults with Moderate-to-Severe Plaque Psoriasis
eurekalert.org
11/29/2023- today.ucsd.edu
11/29/2023
- utu.fi
11/28/2023
- hms.harvard.edu
11/27/2023
- dermatologytimes.com
11/22/2023
- practicaldermatology.com
11/22/2023